Secukinumab shows Higher Symptomatic improvement Versus Etanercept in Psoriatic Arthritis- Comparative Effectiveness Up To 24 Weeks Assessed by Matching-Adjusted Indirect Comparison
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2961
https://www.valueinhealthjournal.com/article/S1098-3015(17)33295-3/fulltext
Title :
Secukinumab shows Higher Symptomatic improvement Versus Etanercept in Psoriatic Arthritis- Comparative Effectiveness Up To 24 Weeks Assessed by Matching-Adjusted Indirect Comparison
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33295-3&doi=10.1016/j.jval.2017.08.2961
First page :
A936
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2711